Who
Joseph Edward Tucker
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Enveric Biosciences; Director, Lakewood-Amedex Biotherapeutics.
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 16 Sep 2021
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —201,124 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —201,124 at $0.00 | filing |
| 24 Apr 2026filed 6 May 2026 | LABT Lakewood-Amedex Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,784 at $0.00 | filing |
| 24 Apr 2026filed 6 May 2026 | LABT Lakewood-Amedex Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,784 at $0.00 | filing |
| 23 Dec 2025filed 30 Dec 2025 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —60,296 at $0.00 | filing |
| 8 May 2025filed 12 May 2025 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —98,866 at $0.00 | filing |
| 9 Oct 2024filed 11 Oct 2024 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —161,633 at $0.00 | filing |
| 22 Feb 2024filed 26 Feb 2024 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 25 Jan 2023filed 27 Jan 2023 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 13 Oct 2021filed 25 Jan 2023 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —1,374 at $0.00 | filing |
| 13 Oct 2021filed 25 Jan 2023 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 16 Sep 2021filed 12 Oct 2021 | ENVB Enveric Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —132,901 | filing |
| 16 Sep 2021filed 12 Oct 2021 | ENVB Enveric Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —531,602 | filing |
| 16 Sep 2021filed 12 Oct 2021 | ENVB Enveric Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,290 | filing |
| 16 Sep 2021filed 12 Oct 2021 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —691,083 | filing |
| 16 Sep 2021filed 27 Sep 2021 | ENVB Enveric Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —199,351 | filing |
| 16 Sep 2021filed 27 Sep 2021 | ENVB Enveric Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —664,503 | filing |
| 16 Sep 2021filed 27 Sep 2021 | ENVB Enveric Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,290 | filing |
| 16 Sep 2021filed 27 Sep 2021 | ENVB Enveric BiosciencesBiotechnology | SEC FORM 4 Code A | —691,083 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.